CDC Call for Applications: Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Other Parasitic Diseases
The purpose of this Centers for Disease Control and Prevention (CDC) funding opportunity Enhancing Capacity for Strategic and Applied Research Activities in Support of Control and Elimination of Malaria and Other Parasitic Diseases is to assist with the implementation of research studies that will provide critical information on ways to monitor, control, and potentially eliminate parasitic diseases including malaria.
Through this funding announcement, the Division of Parasitic Diseases and Malaria seeks to fund critical research and evaluation activities with the potential to yield high impact public health findings and to improve strategies that will decrease the overall burden of parasitic diseases and increase the health and well-being of affected populations. Research topics include identifying and tracking morbidity, developing and testing better diagnostic tools, improving surveillance, and developing and evaluating interventions that can reduce or interrupt transmission of parasitic diseases including reduction of their vectors.
The estimated total program funding is $12,000,000.
Eligible Applicants:
- City or township governments
- Public housing authorities/Indian housing authorities
- Independent school districts
- For profit organizations other than small businesses
- Public and State controlled institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Native American tribal governments (Federally recognized)
- Private institutions of higher education
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Native American tribal organizations (other than Federally recognized tribal governments)
- State governments
- Special district governments
- Small businesses
- County governments
Read more here.
Proposals deadline March 1, 2022.
